Last updated: June 1st, 2016
Clinical endocannabinoid deficiency (CEDC) is a proposed spectrum disorder that has been implicated in a range of illnesses, including fibromyalgia, migraine and irritable bowel syndrome. So far, very little research has been conducted on this speculative disorder, but if it is found to exist, it could be responsible for these very common conditions and may respond favorably to cannabinoid therapies.
Click here to learn more.
Ask Jane a New Question
Have a question about the cannabis plant or its potential medical applications? Ask Jane by first searching Medical Jane’s database of frequently asked questions and answers. Chances are, someone has already asked and answered your question, so be sure to search Medical Jane before asking the Medical Jane community to answer your question.